Dan Groman - Mar 17, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Technology Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Mar 17, 2023
Transactions value $
-$42,414
Form type
4
Date filed
3/21/2023, 04:15 PM
Previous filing
Feb 22, 2023
Next filing
Apr 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale -$42.4 K -3.88 K -4.31% $10.94 86 K Mar 17, 2023 Direct F1

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2022.